The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 10, 2018

Filed:

Apr. 25, 2016
Applicant:

Peptide Biosciences, Inc., Agoura Hills, CA (US);

Inventor:

Elliot Altman, Rockvale, TN (US);

Assignee:

Peptide BioSciences, Inc., Agoura Hills, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 15/62 (2006.01); G01N 33/50 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 7/14 (2006.01); C07K 14/195 (2006.01); C07K 14/245 (2006.01); C07K 14/425 (2006.01); C07K 14/585 (2006.01); C07K 14/59 (2006.01); C07K 14/605 (2006.01); C07K 14/61 (2006.01); C07K 14/62 (2006.01); C07K 14/645 (2006.01); C12N 15/10 (2006.01); C12N 15/63 (2006.01); C12N 15/67 (2006.01); C12N 15/72 (2006.01); C40B 40/02 (2006.01); G01N 33/68 (2006.01); C07K 14/435 (2006.01); C07K 14/46 (2006.01); C07K 14/575 (2006.01); C07K 14/58 (2006.01); C07K 14/63 (2006.01); C07K 14/655 (2006.01); C07K 14/665 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5008 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 7/14 (2013.01); C07K 14/195 (2013.01); C07K 14/245 (2013.01); C07K 14/425 (2013.01); C07K 14/435 (2013.01); C07K 14/43536 (2013.01); C07K 14/43568 (2013.01); C07K 14/43572 (2013.01); C07K 14/463 (2013.01); C07K 14/575 (2013.01); C07K 14/58 (2013.01); C07K 14/585 (2013.01); C07K 14/59 (2013.01); C07K 14/605 (2013.01); C07K 14/61 (2013.01); C07K 14/62 (2013.01); C07K 14/63 (2013.01); C07K 14/645 (2013.01); C07K 14/655 (2013.01); C07K 14/665 (2013.01); C12N 15/1037 (2013.01); C12N 15/62 (2013.01); C12N 15/635 (2013.01); C12N 15/67 (2013.01); C12N 15/72 (2013.01); C40B 40/02 (2013.01); G01N 33/502 (2013.01); G01N 33/5011 (2013.01); G01N 33/5014 (2013.01); G01N 33/68 (2013.01); G01N 33/6845 (2013.01); C07K 2319/00 (2013.01);
Abstract

An intracellular selection system allows screening for peptide bioactivity and stability. Randomized recombinant peptides are screened for bioactivity in a tightly regulated expression system, preferably derived from the wild-type lac operon. Bioactive peptides thus identified are inherently protease- and peptidase-resistant. Also provided are bioactive peptides stabilized by a stabilizing group at the N-terminus, the C-terminus, or both. The stabilizing group can be a small stable protein, such as the Rop protein, glutathione sulfotransferase, thioredoxin, maltose binding protein, or glutathione reductase, an α-helical moiety, or one or more proline residues.


Find Patent Forward Citations

Loading…